Fig. 3 | Scientific Reports

Fig. 3

From: Risedronate prevents exercise-induced hypercalcemia but not nausea or vomit in humans: a double blind randomized controlled trial

Fig. 3

(a, b) Comparison of (a) the incidence and (b) visual analog scale (VAS) scores of nausea or vomiting during or after the heavy exercise between the two groups in the intention-to-treat (ITT) analyses. (c,d) Comparison of serum total calcium (tCa) levels after the heavy exercise between the two groups in the (c) ITT and (d) per-protocol (PP) analyses.

Back to article page